Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Madrigal Pharmaceuticals Inc
(NQ:
MDGL
)
269.40
-4.32 (-1.58%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
356,999
Open
270.00
Bid (Size)
261.00 (1)
Ask (Size)
279.00 (1)
Prev. Close
273.72
Today's Range
265.36 - 283.98
52wk Range
119.76 - 299.98
Shares Outstanding
17,103,395
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Is Madrigal Pharmaceuticals a Millionaire Maker?
June 30, 2024
Its revenue ramp-up is just starting, and its market looks lucrative.
Via
The Motley Fool
Is Madrigal Pharmaceuticals Stock a Buy?
June 28, 2024
The company could become a prominent player in the biotech industry, but that might take a while.
Via
The Motley Fool
Performance
YTD
+18.75%
+18.75%
1 Month
-2.65%
-2.65%
3 Month
+17.98%
+17.98%
6 Month
+12.27%
+12.27%
1 Year
+22.83%
+22.83%
More News
Read More
The Best Biotech Stock to Invest $1,000 in Right Now
June 18, 2024
Via
The Motley Fool
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
June 17, 2024
Via
Investor's Business Daily
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
June 16, 2024
Via
The Motley Fool
Where Will Madrigal Pharmaceuticals Be in 3 Years?
June 15, 2024
Via
The Motley Fool
Is Madrigal Pharmaceuticals Stock a Buy?
May 21, 2024
Via
The Motley Fool
2 Under-the-Radar Growth Stocks to Consider
April 10, 2024
Via
The Motley Fool
1 No-Brainer Growth Stock to Buy Now
April 03, 2024
Via
The Motley Fool
Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
June 12, 2024
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
June 11, 2024
Via
Benzinga
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals
June 10, 2024
Via
The Motley Fool
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
June 05, 2024
Via
Benzinga
Madrigal, Akero, 89bio Tumble After Lilly's Weight-Loss Drug Tackles MASH
June 05, 2024
Via
Investor's Business Daily
DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
June 05, 2024
Via
Benzinga
Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug
June 04, 2024
Via
Investor's Business Daily
The Week Ahead: What's Next
June 02, 2024
Via
Talk Markets
MDGL Stock Earnings: Madrigal Pharmaceuticals Misses EPS for Q1 2024
May 07, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 07, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
May 03, 2024
Via
Benzinga
6 Stocks Positioned to Soar as Investors Focus on MASH
April 22, 2024
Via
TheNewswire.com
7 Stocks Analysts Are Loving Right Now (And You Should Too): April 2024
April 15, 2024
Via
InvestorPlace
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
April 05, 2024
Via
The Motley Fool
The 3 Best Biotech Stocks to Buy in April 2024
April 01, 2024
Via
InvestorPlace
2 Top Biotech Buyout Candidates
March 31, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.